Dose Reduction versus Dose-interval Prolongation in Eribulin Mesilate Monotherapy in Patients with Metastatic Breast Cancer: A Retrospective Comparative Study - Sasaki, Toshinori; Oshima, Yumiko; Mishima, Etsuko; Ban, Akiko; Katsuragawa, Kenji; Nagamatsu, Hidetsugu; Yoshioka, Yuki; Tsukiyama, Ikuto; Hisada, Tatsuya; Itakura, Yukari; Mizutani, Mitsuhiro (YAKUGAKU ZASSHI, 2016)
Keywords: Adult; Aged; Breast Neoplasms - drug therapy; Breast Neoplasms - mortality; dose adjustment; Drug Administration Schedule; Endpoint Determination; eribulin mesilate; Female; Furans - administration & dosage; Furans - adverse effects; Humans; Ketones - administration & dosage; Ketones - adverse effects; metastatic breast cancer; Middle Aged; Neoplasm Recurrence, Local; Peripheral Nervous System Diseases - chemically induced; Peripheral Nervous System Diseases - epidemiology; relative dose intensity; Retrospective Studies; Survival Rate; Treatment Failure; Treatment Outcome